About Mark Bradley
Mark Bradley is EVP, Chief Integration Officer at Keenova Therapeutics plc.
Form D filings name Mark Bradley as an executive vice president; chief financial officer and director at Endo.
Mark Bradley reports to the SEC as an officer of 2 public companies, including Endo International plc (ENDP).
Mark Bradley first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Bradley in the role, so the role may have started earlier or lasted longer.
KP
Keenova Therapeutics plc
EVP, Chief Integration Officer
2025 · Public company
EP
Endo International plc
EVP, Chief Financial Officer
2020 – 2022 · Public company (ENDP)
Key Colleagues at Startups
The people Mark Bradley works with at each company, as listed on that company's latest Form D.
Endo, Inc. · Form D/A, May 6, 2024
SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
Paul Herendeen
Director
MY
Marc Yoskowitz
Director
PB
Patrick Barry
Executive Vice President; President, Global Commercial Operations
BC
Blaise Coleman
President; Chief Executive Officer and director
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
SL
Sophia Langlois
Director
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
AP
Andy Pasternak
Director